| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 265.45 | 227.33 | 106 | 90.71 |
yoy growth (%) | 16.77 | 114.45 | 16.85 | -77.01 |
Raw materials | -108.86 | -113.04 | -79.37 | -72.52 |
As % of sales | 41.01 | 49.72 | 74.87 | 79.94 |
Employee costs | -22.41 | -17.09 | -11.85 | -17.9 |
As % of sales | 8.44 | 7.52 | 11.17 | 19.73 |
Other costs | -98.88 | -74.95 | -33.16 | -30.84 |
As % of sales (Other Cost) | 37.24 | 32.97 | 31.28 | 34 |
Operating profit | 35.29 | 22.23 | -18.38 | -30.55 |
OPM | 13.29 | 9.78 | -17.34 | -33.68 |
Depreciation | -9.12 | -8.95 | -3.66 | -3.25 |
Interest expense | -2.68 | -5.03 | -0.39 | -0.42 |
Other income | 19.96 | 14.56 | 24.26 | 19.06 |
Profit before tax | 43.44 | 22.81 | 1.82 | -15.16 |
Taxes | -8.77 | -1.47 | -2.86 | 0 |
Tax rate | -20.19 | -6.45 | -157.18 | 0 |
Minorities and other | 0 | 0 | 408.61 | 15.15 |
Adj. profit | 34.67 | 21.34 | 407.56 | -0.01 |
Exceptional items | -2.56 | 0 | -1.16 | 0 |
Net profit | 32.11 | 21.34 | 406.4 | -0.01 |
yoy growth (%) | 50.47 | -94.74 | -33,86,825 | -100.11 |
NPM | 12.09 | 9.38 | 383.37 | -0.01 |
Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
